The ω-3 fatty acid α-linolenic acid extends Caenorhabditis elegans lifespan via NHR-49/PPARα and oxidation to oxylipins

Wenbo Qi, Gloria E. Gutierrez, Xiaoli Gao, Hong Dixon, Joe A. McDonough, Ann M. Marini, Alfred L Fisher

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The dietary intake of ω-3 polyunsaturated fatty acids has been linked to a reduction in the incidence of aging-associated disease including cardiovascular disease and stroke. Additionally, long-lived Caenorhabditis elegans glp-1 germ line-less mutant animals show a number of changes in lipid metabolism including the increased production of the ω-3 fatty acid, α-linolenic acid (ALA). Here, we show that the treatment of C. elegans with ALA produces a dose-dependent increase in lifespan. The increased longevity of the glp-1 mutant animals is known to be dependent on both the NHR-49/PPARα and SKN-1/Nrf2 transcription factors, although the mechanisms involved are incompletely understood. We find that ALA treatment increased the lifespan of wild-type worms and that these effects required both of these transcription factors. Specifically, NHR-49 was activated by ALA to promote the expression of genes involved in the β-oxidation of lipids, whereas SKN-1 is not directly activated by ALA, but instead, the exposure of ALA to air results in the oxidation of ALA to a group of compounds termed oxylipins. At least one of the oxylipins activates SKN-1 and enhances the increased longevity resulting from ALA treatment. The results show that ω-3 fatty acids inhibit aging and that these effects could reflect the combined effects of the ω-3 fatty acid and the oxylipin metabolites. The benefits of ω-3 fatty acid consumption on human health may similarly involve the production of oxylipins, and differences in oxylipin conversion could account for at least part of the variability found between observational vs. interventional clinical trials.

Original languageEnglish (US)
Pages (from-to)1125-1135
Number of pages11
JournalAging Cell
Volume16
Issue number5
DOIs
StatePublished - Oct 1 2017
Externally publishedYes

Fingerprint

Oxylipins
Peroxisome Proliferator-Activated Receptors
alpha-Linolenic Acid
Caenorhabditis elegans
Fatty Acids
Acids
Transcription Factors
Unsaturated Fatty Acids
Lipid Metabolism
Germ Cells
Cardiovascular Diseases
Myocardial Infarction
Air
Clinical Trials
Lipids
Gene Expression

Keywords

  • aging
  • Caenorhabditis elegans
  • NHR-49
  • oxylipin
  • SKN-1
  • ω-3 fatty acids

ASJC Scopus subject areas

  • Aging
  • Cell Biology

Cite this

The ω-3 fatty acid α-linolenic acid extends Caenorhabditis elegans lifespan via NHR-49/PPARα and oxidation to oxylipins. / Qi, Wenbo; Gutierrez, Gloria E.; Gao, Xiaoli; Dixon, Hong; McDonough, Joe A.; Marini, Ann M.; Fisher, Alfred L.

In: Aging Cell, Vol. 16, No. 5, 01.10.2017, p. 1125-1135.

Research output: Contribution to journalArticle

Qi, Wenbo ; Gutierrez, Gloria E. ; Gao, Xiaoli ; Dixon, Hong ; McDonough, Joe A. ; Marini, Ann M. ; Fisher, Alfred L. / The ω-3 fatty acid α-linolenic acid extends Caenorhabditis elegans lifespan via NHR-49/PPARα and oxidation to oxylipins. In: Aging Cell. 2017 ; Vol. 16, No. 5. pp. 1125-1135.
@article{fa3258a9fecc445c8b2bb7d1e9aa79a2,
title = "The ω-3 fatty acid α-linolenic acid extends Caenorhabditis elegans lifespan via NHR-49/PPARα and oxidation to oxylipins",
abstract = "The dietary intake of ω-3 polyunsaturated fatty acids has been linked to a reduction in the incidence of aging-associated disease including cardiovascular disease and stroke. Additionally, long-lived Caenorhabditis elegans glp-1 germ line-less mutant animals show a number of changes in lipid metabolism including the increased production of the ω-3 fatty acid, α-linolenic acid (ALA). Here, we show that the treatment of C. elegans with ALA produces a dose-dependent increase in lifespan. The increased longevity of the glp-1 mutant animals is known to be dependent on both the NHR-49/PPARα and SKN-1/Nrf2 transcription factors, although the mechanisms involved are incompletely understood. We find that ALA treatment increased the lifespan of wild-type worms and that these effects required both of these transcription factors. Specifically, NHR-49 was activated by ALA to promote the expression of genes involved in the β-oxidation of lipids, whereas SKN-1 is not directly activated by ALA, but instead, the exposure of ALA to air results in the oxidation of ALA to a group of compounds termed oxylipins. At least one of the oxylipins activates SKN-1 and enhances the increased longevity resulting from ALA treatment. The results show that ω-3 fatty acids inhibit aging and that these effects could reflect the combined effects of the ω-3 fatty acid and the oxylipin metabolites. The benefits of ω-3 fatty acid consumption on human health may similarly involve the production of oxylipins, and differences in oxylipin conversion could account for at least part of the variability found between observational vs. interventional clinical trials.",
keywords = "aging, Caenorhabditis elegans, NHR-49, oxylipin, SKN-1, ω-3 fatty acids",
author = "Wenbo Qi and Gutierrez, {Gloria E.} and Xiaoli Gao and Hong Dixon and McDonough, {Joe A.} and Marini, {Ann M.} and Fisher, {Alfred L}",
year = "2017",
month = "10",
day = "1",
doi = "10.1111/acel.12651",
language = "English (US)",
volume = "16",
pages = "1125--1135",
journal = "Aging Cell",
issn = "1474-9718",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - The ω-3 fatty acid α-linolenic acid extends Caenorhabditis elegans lifespan via NHR-49/PPARα and oxidation to oxylipins

AU - Qi, Wenbo

AU - Gutierrez, Gloria E.

AU - Gao, Xiaoli

AU - Dixon, Hong

AU - McDonough, Joe A.

AU - Marini, Ann M.

AU - Fisher, Alfred L

PY - 2017/10/1

Y1 - 2017/10/1

N2 - The dietary intake of ω-3 polyunsaturated fatty acids has been linked to a reduction in the incidence of aging-associated disease including cardiovascular disease and stroke. Additionally, long-lived Caenorhabditis elegans glp-1 germ line-less mutant animals show a number of changes in lipid metabolism including the increased production of the ω-3 fatty acid, α-linolenic acid (ALA). Here, we show that the treatment of C. elegans with ALA produces a dose-dependent increase in lifespan. The increased longevity of the glp-1 mutant animals is known to be dependent on both the NHR-49/PPARα and SKN-1/Nrf2 transcription factors, although the mechanisms involved are incompletely understood. We find that ALA treatment increased the lifespan of wild-type worms and that these effects required both of these transcription factors. Specifically, NHR-49 was activated by ALA to promote the expression of genes involved in the β-oxidation of lipids, whereas SKN-1 is not directly activated by ALA, but instead, the exposure of ALA to air results in the oxidation of ALA to a group of compounds termed oxylipins. At least one of the oxylipins activates SKN-1 and enhances the increased longevity resulting from ALA treatment. The results show that ω-3 fatty acids inhibit aging and that these effects could reflect the combined effects of the ω-3 fatty acid and the oxylipin metabolites. The benefits of ω-3 fatty acid consumption on human health may similarly involve the production of oxylipins, and differences in oxylipin conversion could account for at least part of the variability found between observational vs. interventional clinical trials.

AB - The dietary intake of ω-3 polyunsaturated fatty acids has been linked to a reduction in the incidence of aging-associated disease including cardiovascular disease and stroke. Additionally, long-lived Caenorhabditis elegans glp-1 germ line-less mutant animals show a number of changes in lipid metabolism including the increased production of the ω-3 fatty acid, α-linolenic acid (ALA). Here, we show that the treatment of C. elegans with ALA produces a dose-dependent increase in lifespan. The increased longevity of the glp-1 mutant animals is known to be dependent on both the NHR-49/PPARα and SKN-1/Nrf2 transcription factors, although the mechanisms involved are incompletely understood. We find that ALA treatment increased the lifespan of wild-type worms and that these effects required both of these transcription factors. Specifically, NHR-49 was activated by ALA to promote the expression of genes involved in the β-oxidation of lipids, whereas SKN-1 is not directly activated by ALA, but instead, the exposure of ALA to air results in the oxidation of ALA to a group of compounds termed oxylipins. At least one of the oxylipins activates SKN-1 and enhances the increased longevity resulting from ALA treatment. The results show that ω-3 fatty acids inhibit aging and that these effects could reflect the combined effects of the ω-3 fatty acid and the oxylipin metabolites. The benefits of ω-3 fatty acid consumption on human health may similarly involve the production of oxylipins, and differences in oxylipin conversion could account for at least part of the variability found between observational vs. interventional clinical trials.

KW - aging

KW - Caenorhabditis elegans

KW - NHR-49

KW - oxylipin

KW - SKN-1

KW - ω-3 fatty acids

UR - http://www.scopus.com/inward/record.url?scp=85026664173&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026664173&partnerID=8YFLogxK

U2 - 10.1111/acel.12651

DO - 10.1111/acel.12651

M3 - Article

VL - 16

SP - 1125

EP - 1135

JO - Aging Cell

JF - Aging Cell

SN - 1474-9718

IS - 5

ER -